Interestingly, the impact of incretins is not limited to diabetes-related cardiac dysfunction, as GLP-1 agonists restored cardiac function in dogs with advanced dilated cardiomyopathy (DCM; Nikolaidis et al., 2004). This evidence concerns the gene GCG and dilated cardiomyopathy.